Health Care • Industrial Specialties
$3.61 ▲ +0.24
(+7.12%)
MKT CAP: $17.5M • VOL: 76.0K
52W L $2 52W H $5
ROARABLE / RQD
D- • 43/100
PIOTROSKI
2 / 9
HSCS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $4.3K | $4.3K | $18.6K |
| YoY Revenue Growth % | -0.7% | -76.6% | — |
| Gross Profit | $2.6K | $2.5K | — |
| Gross Margin % | 59.1% | 56.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.4M | -$8.4M | -$6.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$9.1M | -$8.8M | -$6.6M |
| EBITDA (Normalized) | -$8.4M | -$8.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$7.4M | -$7.4M | -$6.1M |
| Capital Expenditures (CapEx) | $3.6K | $3.2K | — |
| Free Cash Flow (FCF) | -$7.4M | -$7.4M | -$6.1M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.1M | $2.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $205.2K | $1.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HSCS.